GO:0065002 intracellular protein transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0065002 (intracellular protein transmembrane transport) describes the directed movement of proteins across a membrane within a cell, using transporters, pores, or membrane-embedded machinery.
• This process is essential for delivering proteins to organelles such as peroxisomes, lysosomes, the Golgi, and the secretory pathway, and for quality control of misfolded proteins [1,6,7].
• Key molecular players include transmembrane domain-containing proteins, the GOLD-domain seven-transmembrane protein family (e.g., TMEM87A), RER1, DAP12, EDEM, and peroxisome biogenesis factors [1,2,5,7].
• Defects in intracellular protein transmembrane transport are linked to neurodegeneration, lysosomal storage disorders, and cancer, making it a target for therapeutic intervention [5,6].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of transport genes in human cells [1,2,5].
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate research on intracellular protein transmembrane transport.
Description
Intracellular protein transmembrane transport (GO:0065002) is the directed movement of proteins across a membrane within a cell, mediated by transporters, pores, or membrane-embedded protein complexes. This process is fundamental for maintaining organelle identity and function, as it ensures that newly synthesized or recycled proteins reach their correct subcellular destinations, including peroxisomes, lysosomes, the Golgi apparatus, and the secretory pathway [1,6,8]. Unlike bulk cytosolic transport, transmembrane transport requires specialized machinery to overcome the hydrophobic barrier of lipid bilayers, often involving transmembrane domains that act as targeting signals. Researchers study GO:0065002 because its dysregulation underlies a broad spectrum of human diseases, from neurodegenerative disorders to lysosomal storage diseases and cancer [5,6]. For example, the retention of DAP12 in the secretory pathway before assembly with TREM2 highlights how transport defects can impact immune signaling. Similarly, the phase separation of peroxisome biogenesis factors demonstrates that membrane transport is tightly coupled to protein condensation events. Understanding the molecular players and regulatory mechanisms of intracellular protein transmembrane transport is therefore critical for developing targeted therapies. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of GO:0065002, covering its definition, biological significance, key genes, disease associations, and state-of-the-art research methods including CRISPR-based models.
intracellular protein transmembrane transport At A Glance
| GO ID | GO:0065002 |
|---|---|
| GO term | intracellular protein transmembrane transport |
| Ontology | biological_process |
| Synonym | intracellular membrane translocation of a protein; intracellular protein membrane transport; intracellular protein transport across a membrane |
| Major function | Directed movement of proteins across intracellular membranes via transporters or pores |
| Related cellular components | Endoplasmic reticulum, Golgi apparatus, peroxisomes, lysosomes, endosomes |
| Key molecular players | Transmembrane domain proteins, GOLD-domain proteins (TMEM87A), RER1, DAP12, EDEM, peroxisome biogenesis factors |
| Associated diseases | Neurodegeneration, lysosomal storage disorders, cancer, immune dysregulation |
What Is GO:0065002?
GO:0065002, intracellular protein transmembrane transport, is defined by QuickGO as the directed movement of proteins in a cell, from one side of a membrane to another by means of some agent such as a transporter or pore. In simpler terms, it is the process by which proteins are actively moved across cellular membranes to reach different compartments within the cell, rather than simply diffusing or being transported through the cytosol. This term encompasses mechanisms such as protein translocation into organelles, vesicular transport across membranes, and the action of transmembrane channels that facilitate protein movement.
Why Is intracellular protein transmembrane transport Important in Cell Biology?
Intracellular protein transmembrane transport is vital for cellular homeostasis because it governs the delivery of proteins to their correct organelles and the removal of misfolded or damaged proteins. Disruptions in this process can lead to the accumulation of proteins in the wrong compartments, triggering cellular stress and disease. For instance, defects in the transport of lysosomal enzymes cause lysosomal storage disorders, while impaired peroxisomal protein import leads to peroxisome biogenesis disorders. Moreover, the retention of immune receptors like DAP12 in the secretory pathway before assembly with TREM2 underscores the importance of transport fidelity in immune responses. Thus, understanding GO:0065002 is essential for uncovering disease mechanisms and identifying therapeutic targets.
• Maintains organelle function by ensuring correct protein localization.
• Prevents toxic protein aggregation by facilitating quality control transport.
• Enables peroxisome biogenesis through phase separation of transport factors.
• Supports lysosomal function and prevents storage disorders.
• Regulates immune signaling by controlling receptor assembly and transport.
• Contributes to plant cell growth and development via Golgi-mediated transport.
• Is implicated in cancer through altered trafficking of oncoproteins and tumor suppressors.
• Provides targets for therapeutic intervention in neurodegeneration.
• Essential for endosomal microdomain formation and signaling.
• Underpins the secretory pathway and membrane protein homeostasis.
What Happens During intracellular protein transmembrane transport?
Initiation and Cargo Recognition
In simple terms: The cell identifies which proteins need to cross a membrane and tags them for transport.
The process begins with the recognition of cargo proteins that bear specific targeting signals, such as transmembrane domains or signal peptides. These signals are decoded by transport machinery that directs the protein to the appropriate membrane. For example, peroxisome biogenesis is initiated by protein phase separation, where cargo receptors and membrane proteins condense to form a transport-competent platform. Similarly, the GOLD-domain seven-transmembrane helix protein TMEM87A may function in cargo recognition at membranes.
Membrane Targeting and Translocation
In simple terms: The tagged protein is delivered to the membrane and moved across it.
Once recognized, cargo proteins are targeted to the membrane via interactions with transport receptors and membrane-embedded channels. The actual translocation step often requires a transporter or pore that facilitates the movement of the protein across the lipid bilayer. In the secretory pathway, proteins such as DAP12 are retained in the endoplasmic reticulum (ER) by RER1 until they assemble with partners like TREM2, ensuring that only properly assembled complexes proceed. This quality control prevents premature transport of unassembled subunits.
Quality Control and Folding
In simple terms: The cell checks that proteins are correctly folded before allowing them to cross.
Misfolded proteins are recognized by lectin-like chaperones such as calnexin and its acceptor EDEM, which release terminally misfolded glycoproteins for retrotranslocation and degradation. This quality control ensures that only properly folded proteins undergo transmembrane transport, maintaining cellular proteostasis. Disruption of this step can lead to the accumulation of misfolded proteins in the ER, a hallmark of neurodegenerative diseases.
Vesicular Transport and Fusion
In simple terms: Proteins are packaged into vesicles that fuse with target membranes to deliver cargo.
For many intracellular proteins, transmembrane transport occurs via vesicular intermediates. Endosomal microdomains form specialized platforms that sort cargo into vesicles destined for lysosomes, the plasma membrane, or other organelles. In plant cells, protein transport in and out of the Golgi involves similar vesicular mechanisms. The fusion of these vesicles with target membranes completes the delivery of proteins to their final destination.
Lysosomal Delivery and Degradation
In simple terms: Proteins destined for degradation are transported to lysosomes.
Lysosomal protein transport is a key branch of intracellular protein transmembrane transport. Proteins are delivered to lysosomes via vesicular trafficking, where they are degraded by acid hydrolases. Defects in this pathway cause lysosomal storage disorders, highlighting the importance of precise transport for cellular clearance.
Key Genes Involved in GO:0065002 intracellular protein transmembrane transport
The following genes and proteins are central to intracellular protein transmembrane transport, as supported by verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TMEM87A | GOLD-domain seven-transmembrane helix protein, likely involved in membrane trafficking | Structural studies reveal unique architecture for transport |
| RER1 | Retention of unassembled DAP12 in the secretory pathway | Regulates immune receptor assembly and transport |
| DAP12 | Immune signaling adaptor, retained in ER until assembly with TREM2 | Model for quality control in transmembrane transport |
| EDEM | Acceptor of terminally misfolded glycoproteins from calnexin | ER-associated degradation and quality control |
| Calnexin | Lectin chaperone that retains misfolded glycoproteins | Folding and transport checkpoint |
| Peroxisome biogenesis factors | Phase separation to initiate peroxisome formation | Membrane transport in organelle biogenesis |
| TREM2 | Partner of DAP12, involved in immune signaling | Assembly-dependent transport |
| LAMP1 | Lysosomal membrane protein | Marker for lysosomal transport |
| Cathepsin D | Lysosomal hydrolase | Cargo for lysosomal transport |
| Golgi SNAREs | Mediate vesicle fusion at Golgi | Plant protein transport |
| Rab GTPases | Regulate vesicle trafficking | Endosomal microdomain formation |
| ESCRT components | Sort cargo into endosomal microdomains | Endosomal transport |
| COPI/COPII | Vesicle coat proteins for ER-Golgi transport | Secretory pathway |
| V-ATPase | Acidifies lysosomes | Lysosomal function |
| TMEM106B | Lysosomal transmembrane protein | Neurodegeneration |
| Sortilin | Sorts cargo to lysosomes | Lysosomal transport |
| M6P receptor | Targets hydrolases to lysosomes | Lysosomal enzyme transport |
How Is intracellular protein transmembrane transport Regulated?
Intracellular protein transmembrane transport is regulated at multiple levels, including cargo recognition, membrane lipid composition, and signaling pathways. For instance, the phase separation of peroxisome biogenesis factors is a regulated event that initiates transport. In the secretory pathway, the retention of DAP12 by RER1 is a regulatory mechanism that prevents premature transport until assembly with TREM2. Additionally, endosomal microdomains form in response to signaling cues and regulate the sorting of cargo into distinct transport routes. Quality control pathways involving EDEM and calnexin ensure that only properly folded proteins proceed, and this is tightly regulated by ER stress responses. In plant cells, Golgi-mediated transport is regulated by developmental and environmental signals.
intracellular protein transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DAP12 | Neurodegeneration, immune dysregulation | Knockout and point mutation in microglia-like cells |
| TREM2 | Alzheimer's disease | Knock-in of disease variants in iPSC-derived neurons |
| EDEM | ER stress-related disorders | Overexpression and knockout in HEK293 cells |
| LAMP1 | Lysosomal storage disorders | Tagged knock-in for live imaging |
| TMEM87A | Membrane trafficking defects | Knockout in HeLa cells |
Neurodegeneration
Defects in intracellular protein transmembrane transport contribute to neurodegenerative diseases. For example, impaired retention of DAP12 in the secretory pathway can lead to altered TREM2 signaling, which is implicated in Alzheimer's disease and other neurodegenerative conditions. Similarly, dysfunction in lysosomal transport leads to the accumulation of toxic proteins, a hallmark of Parkinson's and Alzheimer's diseases. The quality control of protein folding and transport in the ER is also critical, as chronic ER stress can trigger neuronal death.
Lysosomal Storage Disorders
Lysosomal storage disorders are caused by deficiencies in lysosomal enzymes or transport proteins, leading to the accumulation of undegraded substrates. Proper intracellular protein transmembrane transport is essential for delivering hydrolases to lysosomes, and defects in this process can result in diseases such as Tay-Sachs, Gaucher, and Pompe diseases. Research into the transport mechanisms of lysosomal enzymes is therefore crucial for developing therapies.
Cancer
Altered protein transport can promote cancer by mislocalizing oncoproteins or tumor suppressors. For instance, changes in the transport of immune receptors like DAP12 can affect tumor immune surveillance. Additionally, endosomal microdomains and vesicular trafficking pathways are often hijacked by cancer cells to support proliferation and metastasis. Targeting these transport pathways is an emerging therapeutic strategy.
Immune Dysregulation
The assembly-dependent transport of immune receptors such as DAP12 and TREM2 is critical for immune cell function. Disruption of this process can lead to immunodeficiency or autoimmunity. Understanding the regulatory mechanisms of transmembrane transport in immune cells may reveal new targets for immunomodulatory therapies.
From intracellular protein transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TMEM87A affect membrane transport? | CRISPR knockout in HeLa cells |
| How does DAP12 retention regulate TREM2 signaling? | Point mutation of RER1 binding site in DAP12 |
| Can disease-associated TREM2 variants alter transport? | Knock-in of TREM2 variants in iPSCs |
| Where does EDEM localize during ER stress? | Tagged knock-in of EDEM with GFP |
| Does overexpression of peroxisome biogenesis factors induce phase separation? | Overexpression in fibroblasts |
| What is the role of endosomal microdomains in cargo sorting? | Knockout of ESCRT components |
How to Study the intracellular protein transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Confocal microscopy | Localization and movement of tagged proteins | Tracking ER-to-Golgi transport |
| Proteomics | Protein composition of transport intermediates | Identifying novel transport factors |
| CRISPR knockout screen | Genes required for transport | Discovering regulators of peroxisome biogenesis |
| In vitro transport assay | Translocation efficiency across membranes | Studying lysosomal enzyme delivery |
| Live-cell imaging | Real-time vesicle trafficking | Endosomal microdomain dynamics |
| Co-immunoprecipitation | Protein-protein interactions | Assembly of DAP12-TREM2 |
| Flow cytometry | Surface expression of transported proteins | Quality control of immune receptors |
| Electron microscopy | Ultrastructure of organelles | Peroxisome biogenesis |
Fluorescence Microscopy and Live Imaging
Fluorescence microscopy, including confocal and super-resolution techniques, allows visualization of protein transport in real time. Tagged proteins (e.g., GFP-fusions) can be tracked from the ER to the Golgi or lysosomes, revealing transport kinetics and defects. Live imaging of endosomal microdomains has elucidated their role in cargo sorting.
Proteomics and Mass Spectrometry
Proteomic approaches identify proteins that co-purify with transport machinery or that are enriched in specific membrane fractions. For example, mass spectrometry of isolated lysosomes can reveal defects in hydrolase delivery. Proximity labeling techniques can map the interactome of transport receptors.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout screens can identify genes required for intracellular protein transmembrane transport. Such screens have uncovered novel regulators of peroxisome biogenesis and lysosomal transport [1,6]. These approaches are powerful for unbiased discovery of transport components.
Biochemical Transport Assays
In vitro transport assays using isolated membranes or semi-permeabilized cells measure the translocation of radiolabeled or fluorescently tagged proteins across membranes. These assays have been instrumental in dissecting the steps of lysosomal protein transport and ER quality control.
How CRISPR Can Be Used to Study GO:0065002 intracellular protein transmembrane transport
Knockout
CRISPR knockout is used to completely ablate genes involved in intracellular protein transmembrane transport, such as TMEM87A or RER1, to assess their necessity for cargo delivery [2,5]. Knockout cell lines can be generated in various cell types, including HeLa and iPSCs, and analyzed by imaging and biochemical assays.
Point Mutation
Point mutations can be introduced to dissect specific residues required for transport, such as the RER1-binding motif in DAP12. This approach allows fine-tuning of protein function without completely eliminating the protein, revealing subtle transport defects.
Knock-in
Knock-in of tagged or disease-associated variants (e.g., TREM2 variants) enables tracking of endogenous proteins and modeling of human disease. Fluorescent tags like GFP or HaloTag can be knocked into the endogenous locus for live imaging of transport.
Overexpression
Overexpression of transport factors or cargo proteins can be achieved by CRISPR activation or by introducing expression constructs. This is useful for studying gain-of-function effects, such as the phase separation of peroxisome biogenesis factors.
How EDITGENE Supports intracellular protein transmembrane transport Research
Researchers studying intracellular protein transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in transport, and which domains or residues are required. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from knockout to precise point mutations and knock-ins, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for intracellular protein transmembrane transport research.
Frequently Asked Questions About intracellular protein transmembrane transport
What is intracellular protein transmembrane transport?
It is the directed movement of proteins across a membrane within a cell, using transporters or pores, as defined by GO:0065002.
What genes are involved in intracellular protein transmembrane transport?
Key genes include TMEM87A, RER1, DAP12, EDEM, and peroxisome biogenesis factors, among others [1,2,5,7].
Why is intracellular protein transmembrane transport important?
It ensures proteins reach correct organelles, maintains cellular homeostasis, and its defects cause diseases like neurodegeneration and lysosomal storage disorders [5,6].
How is intracellular protein transmembrane transport regulated?
It is regulated by cargo recognition, phase separation, quality control pathways, and signaling cues [1,4,7].
What diseases are associated with defects in intracellular protein transmembrane transport?
Neurodegeneration, lysosomal storage disorders, cancer, and immune dysregulation [5,6].
What methods are used to study intracellular protein transmembrane transport?
Fluorescence microscopy, proteomics, CRISPR screens, and in vitro transport assays [1,6].
How can CRISPR be used to study intracellular protein transmembrane transport?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal dissection of transport genes [2,5].
What is the role of TMEM87A in intracellular protein transmembrane transport?
TMEM87A is a GOLD-domain seven-transmembrane protein likely involved in membrane trafficking, though its exact function is under study.
How does DAP12 relate to intracellular protein transmembrane transport?
DAP12 is retained in the secretory pathway by RER1 until assembly with TREM2, illustrating quality control in transport.
What is the connection between peroxisome biogenesis and intracellular protein transmembrane transport?
Peroxisome biogenesis is initiated by protein phase separation, a form of intracellular protein transmembrane transport.
Conclusion
Intracellular protein transmembrane transport (GO:0065002) is a fundamental cellular process that ensures proteins reach their correct destinations within the cell. Its dysregulation is linked to a wide range of diseases, from neurodegeneration to lysosomal storage disorders and cancer. Advances in CRISPR-based models and imaging technologies are rapidly expanding our understanding of the molecular mechanisms and regulatory networks involved. EDITGENE's comprehensive CRISPR services, including knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics, empower researchers to dissect these pathways and develop novel therapeutic strategies.
References
- 1. Ravindran R et al.. 2023. Peroxisome biogenesis initiated by protein phase separation.. Nature 617(7961):608-615 PMID: 37165185
- 2. Hoel CM et al.. 2022. Structure of the GOLD-domain seven-transmembrane helix protein family member TMEM87A.. Elife 11 PMID: 36373655
- 3. Cosson P et al.. 2013. Anchors aweigh: protein localization and transport mediated by transmembrane domains.. Trends Cell Biol 23(10):511-7 PMID: 23806646
- 4. Norris A et al.. 2020. Endosomal microdomains: Formation and function.. Curr Opin Cell Biol 65:86-95 PMID: 32247230
- 5. Liu Y et al.. 2024. DAP12 interacts with RER1 and is retained in the secretory pathway before assembly with TREM2.. Cell Mol Life Sci 81(1):302 PMID: 39008111
- 6. Schaub BE et al.. 2005. Analysis of protein transport to lysosomes.. Curr Protoc Cell Biol Chapter 15:15.8.1-15.8.12 PMID: 18228463
- 7. Oda Y et al.. 2003. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin.. Science 299(5611):1394-7 PMID: 12610305
- 8. Neumann U et al.. 2003. Protein transport in plant cells: in and out of the Golgi.. Ann Bot 92(2):167-80 PMID: 12876187
